Healing of Benign Gastric and Prepyloric Ulcers: A Prospective, Endoscopy-Controlled, Randomized, Double-Blind, Canadian Multicentre Study of Omeprazole 20 and 40 mg Daily and Rantidine 150 mg Twice a Day

A double-blind, randomized study was conducted in 118 patients with benign gastric or prepyloric ulcers to compare the efficacy of omeprazole 20 or 40 mg daily with ranitidine 150 mg twice daily. The healing rates at four weeks were 67, 79 and 54% and at eight weeks increased to 90, 97 and 71 % for...

Full description

Saved in:
Bibliographic Details
Main Authors: Pierre Paré, Robert J Bailey, André P Archambault, Henri Navert, C Noel Williams, ABR Thomson, Denis Levesque, Alain Farley
Format: Article
Language:English
Published: Wiley 1990-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/1990/437472
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564344860180480
author Pierre Paré
Robert J Bailey
André P Archambault
Henri Navert
C Noel Williams
ABR Thomson
Denis Levesque
Alain Farley
author_facet Pierre Paré
Robert J Bailey
André P Archambault
Henri Navert
C Noel Williams
ABR Thomson
Denis Levesque
Alain Farley
author_sort Pierre Paré
collection DOAJ
description A double-blind, randomized study was conducted in 118 patients with benign gastric or prepyloric ulcers to compare the efficacy of omeprazole 20 or 40 mg daily with ranitidine 150 mg twice daily. The healing rates at four weeks were 67, 79 and 54% and at eight weeks increased to 90, 97 and 71 % for the omeprazole 20 and 40 mg groups and the ranitidine group, respectively (P< 0.03 for the differences between each of the omeprazole groups and the ranitidine group at eight weeks). Multivariate analysis showed influence on healing rate for ulcer size but not for smoking status, sex or ulcer site. Symptomatic relief was excellent and similar in the three groups. Ulcer recurrence during the six month follow-up off treatment after initial ulcer healing did not differ between the three groups. No serious adverse events could be attributed to the drugs. The authors conclude that treatment with omeprazole 20 or 40 mg daily for a period of four to eight weeks is safe and significantly more effective in ulcer healing than a standard dose of ranitidine.
format Article
id doaj-art-8c8d7b8b222f4e898e495cce220a9f27
institution Kabale University
issn 0835-7900
language English
publishDate 1990-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-8c8d7b8b222f4e898e495cce220a9f272025-02-03T01:11:20ZengWileyCanadian Journal of Gastroenterology0835-79001990-01-014171210.1155/1990/437472Healing of Benign Gastric and Prepyloric Ulcers: A Prospective, Endoscopy-Controlled, Randomized, Double-Blind, Canadian Multicentre Study of Omeprazole 20 and 40 mg Daily and Rantidine 150 mg Twice a DayPierre Paré0Robert J Bailey1André P Archambault2Henri Navert3C Noel Williams4ABR Thomson5Denis Levesque6Alain Farley7Division of Gastroenterology, Hôtel-Dieu de Québec Hospital, Laval University, Quebec City, Quebec, CanadaInternal Medicine, Royal Alexandra Hospital, Edmonton, Alberta, CanadaInternal Medicine, Royal Alexandra Hospital, Edmonton, Alberta, CanadaInternal Medicine, Royal Alexandra Hospital, Edmonton, Alberta, CanadaInternal Medicine, Royal Alexandra Hospital, Edmonton, Alberta, CanadaInternal Medicine, Royal Alexandra Hospital, Edmonton, Alberta, CanadaDivision of Gastroenterology, Hôtel-Dieu de Québec Hospital, Laval University, Quebec City, Quebec, CanadaInternal Medicine, Royal Alexandra Hospital, Edmonton, Alberta, CanadaA double-blind, randomized study was conducted in 118 patients with benign gastric or prepyloric ulcers to compare the efficacy of omeprazole 20 or 40 mg daily with ranitidine 150 mg twice daily. The healing rates at four weeks were 67, 79 and 54% and at eight weeks increased to 90, 97 and 71 % for the omeprazole 20 and 40 mg groups and the ranitidine group, respectively (P< 0.03 for the differences between each of the omeprazole groups and the ranitidine group at eight weeks). Multivariate analysis showed influence on healing rate for ulcer size but not for smoking status, sex or ulcer site. Symptomatic relief was excellent and similar in the three groups. Ulcer recurrence during the six month follow-up off treatment after initial ulcer healing did not differ between the three groups. No serious adverse events could be attributed to the drugs. The authors conclude that treatment with omeprazole 20 or 40 mg daily for a period of four to eight weeks is safe and significantly more effective in ulcer healing than a standard dose of ranitidine.http://dx.doi.org/10.1155/1990/437472
spellingShingle Pierre Paré
Robert J Bailey
André P Archambault
Henri Navert
C Noel Williams
ABR Thomson
Denis Levesque
Alain Farley
Healing of Benign Gastric and Prepyloric Ulcers: A Prospective, Endoscopy-Controlled, Randomized, Double-Blind, Canadian Multicentre Study of Omeprazole 20 and 40 mg Daily and Rantidine 150 mg Twice a Day
Canadian Journal of Gastroenterology
title Healing of Benign Gastric and Prepyloric Ulcers: A Prospective, Endoscopy-Controlled, Randomized, Double-Blind, Canadian Multicentre Study of Omeprazole 20 and 40 mg Daily and Rantidine 150 mg Twice a Day
title_full Healing of Benign Gastric and Prepyloric Ulcers: A Prospective, Endoscopy-Controlled, Randomized, Double-Blind, Canadian Multicentre Study of Omeprazole 20 and 40 mg Daily and Rantidine 150 mg Twice a Day
title_fullStr Healing of Benign Gastric and Prepyloric Ulcers: A Prospective, Endoscopy-Controlled, Randomized, Double-Blind, Canadian Multicentre Study of Omeprazole 20 and 40 mg Daily and Rantidine 150 mg Twice a Day
title_full_unstemmed Healing of Benign Gastric and Prepyloric Ulcers: A Prospective, Endoscopy-Controlled, Randomized, Double-Blind, Canadian Multicentre Study of Omeprazole 20 and 40 mg Daily and Rantidine 150 mg Twice a Day
title_short Healing of Benign Gastric and Prepyloric Ulcers: A Prospective, Endoscopy-Controlled, Randomized, Double-Blind, Canadian Multicentre Study of Omeprazole 20 and 40 mg Daily and Rantidine 150 mg Twice a Day
title_sort healing of benign gastric and prepyloric ulcers a prospective endoscopy controlled randomized double blind canadian multicentre study of omeprazole 20 and 40 mg daily and rantidine 150 mg twice a day
url http://dx.doi.org/10.1155/1990/437472
work_keys_str_mv AT pierrepare healingofbenigngastricandprepyloriculcersaprospectiveendoscopycontrolledrandomizeddoubleblindcanadianmulticentrestudyofomeprazole20and40mgdailyandrantidine150mgtwiceaday
AT robertjbailey healingofbenigngastricandprepyloriculcersaprospectiveendoscopycontrolledrandomizeddoubleblindcanadianmulticentrestudyofomeprazole20and40mgdailyandrantidine150mgtwiceaday
AT andreparchambault healingofbenigngastricandprepyloriculcersaprospectiveendoscopycontrolledrandomizeddoubleblindcanadianmulticentrestudyofomeprazole20and40mgdailyandrantidine150mgtwiceaday
AT henrinavert healingofbenigngastricandprepyloriculcersaprospectiveendoscopycontrolledrandomizeddoubleblindcanadianmulticentrestudyofomeprazole20and40mgdailyandrantidine150mgtwiceaday
AT cnoelwilliams healingofbenigngastricandprepyloriculcersaprospectiveendoscopycontrolledrandomizeddoubleblindcanadianmulticentrestudyofomeprazole20and40mgdailyandrantidine150mgtwiceaday
AT abrthomson healingofbenigngastricandprepyloriculcersaprospectiveendoscopycontrolledrandomizeddoubleblindcanadianmulticentrestudyofomeprazole20and40mgdailyandrantidine150mgtwiceaday
AT denislevesque healingofbenigngastricandprepyloriculcersaprospectiveendoscopycontrolledrandomizeddoubleblindcanadianmulticentrestudyofomeprazole20and40mgdailyandrantidine150mgtwiceaday
AT alainfarley healingofbenigngastricandprepyloriculcersaprospectiveendoscopycontrolledrandomizeddoubleblindcanadianmulticentrestudyofomeprazole20and40mgdailyandrantidine150mgtwiceaday